The Brutalist Report - business
- Jazz Pharmaceuticals Releases Unexpected Phase 4 Results Highlighting Xywav® [236d]
- Axsome’s AXS-14 Gets Regulatory Setback with RTF, says Morgan Stanley [236d]
- BridgeBio Pharma, Inc. (BBIO) Price Target Raised to $56 from $53 at H.C. Wainwright [236d]
- TransCon® hGH Boosts TransCon® CNP Results in Kids with Achondroplasia by Week 26 [236d]
- Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM) [236d]
- US Appeals Court Confirms Patent Validity of Acadia’s Parkinson’s Medication [236d]
- Voyager Technologies Rises in Debut, Signaling Improving IPO Market [236d]
- Vertex Presents New Data on the Benefits of ALYFTREK [237d]
- Coinbase claims to reduce account freezes by 82% [237d]
- Wall Street’s hottest ETF hits $70B five times faster than S&P 500 and gold ETFs [237d]
- The European Commission Approves Alnylam’s AMVUTTRA [237d]
- Google Expands Buyouts In Search And Ads Division As AI Reshapes Priorities [237d]
- Joby Aviation Stock (JOBY) Takes Flight Upon Donald Trump’s Executive Order [237d]
- Stock market today: Dow, S&P 500, Nasdaq futures slide ahead of fresh inflation data, as Trump renews tariff threat [237d]
- Stock market today: Dow, S&P 500, Nasdaq futures slip as Trump renews tariff threats [237d]
- Surprising inflation, China news sends S&P 500 stumbling [237d]
- Toyota chairman re-elected against backdrop of $33 billion buyout bid [237d]
- Dave Ramsey Presents A Roadmap For A High-Spending Couple That's More Than $200,000 In Debt: 'The Problem Is Not The Credit Card Debt' [237d]
- No new articles in the Past Hour.
- No new articles in the Past Hour.
- No new articles in the Past Hour.
- No new articles in the Past Hour.
- No new articles in the Past Hour.
Previous Day